ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RVNC Revance Therapeutics Inc

2.83
-0.14 (-4.71%)
Jun 15 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 561.88M711.59M581.9M547.8M597.54M532.49M478.45M508.12M
Total Current Assets 260.95M415.59M374.73M323.02M378.95M388.52M338.87M369.69M
Cash and Equivalents 69.42M104.49M108.97M136.68M141.24M179.32M137.33M132.61M
Total Non-Current Assets 306.14M308.65M222.92M210.92M192.13M120.76M119.77M138.43M
Total Liabilities 564.51M565.88M569.3M574.47M570.75M638.69M630.06M606.79M
Total Current Liabilities 77.23M74.73M75.68M77.99M74.08M82.16M89.22M68.9M
Total Non-Current Liabilities 865.67M870.04M872.99M876.35M877.02M983.63M967.43M962.73M
Common Equity 73k82k82k84k88k88k88k104k
Retained Earnings -1.52B-1.61B-1.75B-1.81B-1.88B-2.02B-2.08B-2.13B
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 204.36M295.7M226.35M340.29M720.22M531.16M581.9M478.45M
Total Current Assets 192.7M285.21M207.92M296.6M450M246.12M374.73M338.87M
Cash and Equivalents 63.5M282.9M73.26M170.46M333.56M110.62M108.97M137.33M
Total Non-Current Assets 177.07M268.85M145.62M225.49M374.29M68.47M12.6M-151.6M
Total Liabilities 27.29M26.85M80.73M114.8M345.93M462.69M569.3M630.06M
Total Current Liabilities 19.65M20.9M31.97M40.98M60.96M67.29M75.68M89.22M
Total Non-Current Liabilities 9.51M5.95M48.76M73.82M465.49M676.04M872.99M967.43M
Total Equity 177.07M268.85M145.62M225.49M374.29M68.47M12.6M-151.6M
Common Equity 29k37k37k52k69k72k82k88k
Retained Earnings -421.54M-542.17M-684.78M-844.2M-1.13B-1.4B-1.75B-2.08B

Your Recent History

Delayed Upgrade Clock